Drug companies often promote products during events or sales visits to doctors. This type of marketing is known as detailing because doctors learn details about drug benefits and side effects. Doctors may also receive gifts such as meals and free samples. Some academic medical centers have begun to restrict detailing. But little is known about the impact of detailing on prescribing practices. A team led by Dr. Ian Larkin at the University of California, Los Angeles, and Dr. George Loewenstein at Carnegie Mellon University examined whether policies to limit detailing affect prescription patterns. They examined prescriptions in 19 academic medical centers that restricted detailing from January 2006 to June 2012. More than 2,000 doctors were affiliated with the centers. For comparison, the team examined prescriptions by nearly 25,000 doctors who weren’t at the centers. The analysis included more than 16 million prescriptions in eight major drug classes. Read more about the study: https://news.nnlm.gov/bhic/6fwf
Email Emily Hamstra (email@example.com) to receive a digest of the day’s BHIC posts via email.